Login to Your Account



Industry-friendly tax to help boost China investment in biotech

By Cornelia Zou
Staff Writer

Wednesday, July 9, 2014

HONG KONG – Starting this month, Chinese biotech companies will enjoy a 50 percent reduction in value-added tax (VAT) in China, all part of a government plan to standardize taxes across the country.

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription